Erba Diagnostics, Inc. (ERBA) SEC Filing 8-K Material Event for the period ending Tuesday, July 31, 2018

Erba Diagnostics, Inc.

CIK: 1095858 Ticker: ERBA

View differences made from one to another to evaluate Erba Diagnostics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Erba Diagnostics, Inc..


Assess how Erba Diagnostics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Erba Diagnostics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Erba Diagnostics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ERBA
CIK: 1095858
Form Type: 8-K Corporate News
Accession Number: 0001437749-18-014144
Submitted to the SEC: Wed Aug 01 2018 8:16:31 AM EST
Accepted by the SEC: Wed Aug 01 2018
Period: Tuesday, July 31, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: